Does TOBRAMYCIN Cause Chronic obstructive pulmonary disease? 70 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Chronic obstructive pulmonary disease have been filed in association with TOBRAMYCIN (TOBRAMYCIN). This represents 0.6% of all adverse event reports for TOBRAMYCIN.
70
Reports of Chronic obstructive pulmonary disease with TOBRAMYCIN
0.6%
of all TOBRAMYCIN reports
13
Deaths
50
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From TOBRAMYCIN?
Of the 70 reports, 13 (18.6%) resulted in death, 50 (71.4%) required hospitalization.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOBRAMYCIN. However, 70 reports have been filed with the FAERS database.
What Other Side Effects Does TOBRAMYCIN Cause?
Off label use (1,467)
Death (888)
Cough (738)
Dyspnoea (706)
Pneumonia (700)
Hospitalisation (688)
Condition aggravated (669)
Cystic fibrosis (646)
Infective pulmonary exacerbation of cystic fibrosis (504)
Drug ineffective (453)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
MEPOLIZUMAB (1,107)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)
Which TOBRAMYCIN Alternatives Have Lower Chronic obstructive pulmonary disease Risk?
TOBRAMYCIN vs TOBRAMYCIN\TOBRAMYCIN
TOBRAMYCIN vs TOCILIZUMAB
TOBRAMYCIN vs TOCILIZUMAB-AAZG
TOBRAMYCIN vs TOCOPHEROL
TOBRAMYCIN vs TOFACITINIB